Abdullah E Al-Anazi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Diffuse Large B Cell Lymphoma

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Maaweya E Awadalla, Haitham Alkadi, Modhi Alarjani, Abdullah E Al-Anazi, Mohanad A Ibrahim, Thamer Ahmad ALOhali, Mushira Enani, Wael Alturaiki, Bandar Alosaimi
Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains. Vaccines 11 (6) (2023)
Reham M Alahmadi, Najat Marraiki, Mohammed Alswayyed, Hatim A Khoja, Abdullah E Al-Anazi, Rawan M Alahmadi, Meshael M Alkusayer, Bandar Alosaimi, Maaweya Awadalla
Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma. Cancers 15 (23) (2023)
Abdullah E Al-Anazi, Bader S Alanazi, Huda M Alshanbari, Emad M Masuadi, Maaweya E Hamed, Iman Dandachi, Abdulrahman Alkathiri, Atif Hanif, Islam Nour, Hanadi Fatani, Hadel Alsaran, Fahad AlKhareeb, Ali Al Zahrani, Abdullah A Alsharm, Saleh Eifan, Bandar Alosaimi
Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study. Cancers 15 (3) (2023)
Abdullah E Al-Anazi, Bader S Alanazi, Huda M Alshanbari, Emad M Masuadi, Maaweya E Hamed, Iman Dandachi, Abdulrahman Alkathiri, Atif Hanif, Islam Nour, Hanadi Fatani, Hadel Alsaran, Fahad AlKhareeb, Ali Al Zahrani, Abdullah A Alsharm, Saleh Eifan, Bandar Alosaimi
Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study. Cancers 15 (3) (2023)
Maaweya E Awadalla, Haitham Alkadi, Modhi Alarjani, Abdullah E Al-Anazi, Mohanad A Ibrahim, Thamer Ahmad ALOhali, Mushira Enani, Wael Alturaiki, Bandar Alosaimi
Moderately Low Effectiveness of the Influenza Quadrivalent Vaccine: Potential Mismatch between Circulating Strains and Vaccine Strains. Vaccines 11 (6) (2023)